FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318274804> ?p ?o ?g. }

• W4318274804 endingPage "111018" @default.
• W4318274804 startingPage "111018" @default.
• W4318274804 abstract "Prostate cancer showcases remarkable clinical heterogeneity. Long-term treatment targeting androgen/androgen receptor-axis may drive patients to develop castration-resistant and more aggressive neuroendocrine phenotypes. The tumor immune microenvironment (TIME) presents activation of multiple progression-related programs. It is generally considered that TGFβ secreted by prostate cancer cell leads to inhibitory activity of effector T lymphocytes and contributes to inhibitory TIME by activation of TGFβ signaling pathway. However, the mechanisms regulating mRNA splicing and expression of TGFβ are poorly understood. Here we hypothesize that Jumonji domain-containing 6 (JMJD6), previously as a histone demethylase, underlies the function of aiding alternative splicing of TGFβ mRNA, which promote TGFβ production and secretion, and activate TGFβ signal pathway from upstream links, eventually forming immunosuppressive TIME and inducing therapeutic resistance. We identify that JMJD6 interacts with multiple splicing cofactors including serine/arginine enriched splicing factor 8 (SRSF8), heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1) and heterogeneous nuclear ribonucleoprotein K (HNRNPK) based on mass spectrometry analysis. Moreover, the obviously positive relationships occur among JMJD6, SRSF8/HNRNPA2B1/HNRNPK and TGFβ based on database analysis. In view of limited clinical efficacies of using neutralizing antibody of TGFβ, TGFβ receptor inhibitor and TGF-β/PD-L1 coupled antibodies targeting TGFβ signal pathway and delaying tumor progression, our data provide a novel therapeutic insight on blocking TGFβ production from transcription/mRNA splicing level through targeting JMJD6. Our results suggest that targeting the JMJD6/TGF-β Axis can combine with immunotherapies targeting TGFβ signal pathway in TIME to achieve great benefits for treating prostate cancer progression. Combination with JMJD6 antagonist and immunotherapy can sensitize the anti-tumor effect produced by targeting TGFβ signal pathway, block the production of TGFβ from the origin and solve the bottleneck of immunotherapy for prostate cancer." @default.
• W4318274804 created "2023-01-28" @default.
• W4318274804 creator A5038906848 @default.
• W4318274804 creator A5061439013 @default.
• W4318274804 creator A5064066586 @default.
• W4318274804 date "2023-02-01" @default.
• W4318274804 modified "2023-09-25" @default.
• W4318274804 title "Targeting the JMJD6/TGF-β axis in prostate cancer by immunotherapy: A potential treatment based on RNA splicing" @default.
• W4318274804 cites W145664544 @default.
• W4318274804 cites W2083275395 @default.
• W4318274804 cites W2262087934 @default.
• W4318274804 cites W2462711625 @default.
• W4318274804 cites W2618575812 @default.
• W4318274804 cites W2790923203 @default.
• W4318274804 cites W2804412686 @default.
• W4318274804 cites W2963730860 @default.
• W4318274804 cites W2963956483 @default.
• W4318274804 cites W3008451822 @default.
• W4318274804 cites W3038632268 @default.
• W4318274804 cites W3093992907 @default.
• W4318274804 cites W3094504206 @default.
• W4318274804 cites W3118407787 @default.
• W4318274804 cites W3129559641 @default.
• W4318274804 cites W3149714833 @default.
• W4318274804 cites W3185231871 @default.
• W4318274804 cites W3186815806 @default.
• W4318274804 cites W3205771346 @default.
• W4318274804 cites W3206061095 @default.
• W4318274804 cites W3217209761 @default.
• W4318274804 cites W4221125791 @default.
• W4318274804 cites W4224314490 @default.
• W4318274804 cites W4288096597 @default.
• W4318274804 cites W4296981988 @default.
• W4318274804 cites W4303413582 @default.
• W4318274804 cites W4310211625 @default.
• W4318274804 doi "https://doi.org/10.1016/j.mehy.2023.111018" @default.
• W4318274804 hasPublicationYear "2023" @default.
• W4318274804 type Work @default.
• W4318274804 citedByCount "0" @default.
• W4318274804 crossrefType "journal-article" @default.
• W4318274804 hasAuthorship W4318274804A5038906848 @default.
• W4318274804 hasAuthorship W4318274804A5061439013 @default.
• W4318274804 hasAuthorship W4318274804A5064066586 @default.
• W4318274804 hasConcept C104317684 @default.
• W4318274804 hasConcept C105580179 @default.
• W4318274804 hasConcept C118131993 @default.
• W4318274804 hasConcept C121608353 @default.
• W4318274804 hasConcept C194583182 @default.
• W4318274804 hasConcept C2776107976 @default.
• W4318274804 hasConcept C2780192828 @default.
• W4318274804 hasConcept C3020616263 @default.
• W4318274804 hasConcept C502942594 @default.
• W4318274804 hasConcept C51785407 @default.
• W4318274804 hasConcept C54355233 @default.
• W4318274804 hasConcept C54458228 @default.
• W4318274804 hasConcept C61367390 @default.
• W4318274804 hasConcept C62478195 @default.
• W4318274804 hasConcept C64927066 @default.
• W4318274804 hasConcept C67705224 @default.
• W4318274804 hasConcept C73758832 @default.
• W4318274804 hasConcept C86803240 @default.
• W4318274804 hasConcept C95444343 @default.
• W4318274804 hasConceptScore W4318274804C104317684 @default.
• W4318274804 hasConceptScore W4318274804C105580179 @default.
• W4318274804 hasConceptScore W4318274804C118131993 @default.
• W4318274804 hasConceptScore W4318274804C121608353 @default.
• W4318274804 hasConceptScore W4318274804C194583182 @default.
• W4318274804 hasConceptScore W4318274804C2776107976 @default.
• W4318274804 hasConceptScore W4318274804C2780192828 @default.
• W4318274804 hasConceptScore W4318274804C3020616263 @default.
• W4318274804 hasConceptScore W4318274804C502942594 @default.
• W4318274804 hasConceptScore W4318274804C51785407 @default.
• W4318274804 hasConceptScore W4318274804C54355233 @default.
• W4318274804 hasConceptScore W4318274804C54458228 @default.
• W4318274804 hasConceptScore W4318274804C61367390 @default.
• W4318274804 hasConceptScore W4318274804C62478195 @default.
• W4318274804 hasConceptScore W4318274804C64927066 @default.
• W4318274804 hasConceptScore W4318274804C67705224 @default.
• W4318274804 hasConceptScore W4318274804C73758832 @default.
• W4318274804 hasConceptScore W4318274804C86803240 @default.
• W4318274804 hasConceptScore W4318274804C95444343 @default.
• W4318274804 hasFunder F4320316908 @default.
• W4318274804 hasFunder F4320321550 @default.
• W4318274804 hasLocation W43182748041 @default.
• W4318274804 hasOpenAccess W4318274804 @default.
• W4318274804 hasPrimaryLocation W43182748041 @default.
• W4318274804 hasRelatedWork W1178255197 @default.
• W4318274804 hasRelatedWork W1982559739 @default.
• W4318274804 hasRelatedWork W2037700362 @default.
• W4318274804 hasRelatedWork W2166242782 @default.
• W4318274804 hasRelatedWork W2926723874 @default.
• W4318274804 hasRelatedWork W2943886463 @default.
• W4318274804 hasRelatedWork W3034742762 @default.
• W4318274804 hasRelatedWork W3083034993 @default.
• W4318274804 hasRelatedWork W3122965712 @default.
• W4318274804 hasRelatedWork W4361833577 @default.
• W4318274804 hasVolume "171" @default.
• W4318274804 isParatext "false" @default.

• next